Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Rectal Neoplasms 1 Radiation Injuries 1 Multiple Myeloma 1 Multiple Chronic Conditions 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Hematologic Neoplasms 1 Fatigue 1 Cognitive Dysfunction 1 Carcinoma, Basal Cell 1 Breast Neoplasms 1 Breast Neoplasm Female 1 Brain Neoplasms 1

Interventions

Tomography, Optical Coherence 3 Biopsy 3 methyl 5-aminolevulinate 2 daromun 2 Mohs Surgery 2 Imiquimod 2 Aminolevulinic Acid 2 Watchful Waiting 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Solutions 1 Patient Reported Outcome Measures 1 Nivolumab 1 Niacinamide 1 Methylation 1 Itraconazole 1 Immunologic Factors 1 Hydrogen Peroxide 1 Glatiramer Acetate 1 Fluorouracil 1 Electroporation 1 Dermoscopy 1 Curettage 1 Cryotherapy 1 Coat Protein Complex I 1 Cautery 1 Capecitabine 1 Calcium Chloride 1 BF-200 ALA 1 5-aminolevulinic acid hexyl ester 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Carcinoma, Basal Cell × Patient Reported Outcome Measures × Clear all

NCT06448936 2025-04-03

FACE-QOL

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡